US82489T1043 - Common Stock
On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94.
SANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...
These three well-established growth stocks could be on the way to something much bigger.
SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) qualifies as a high growth stock and is consolidating.
Four recent big earnings movers also are on this week's watchlist.
A big stock market week for AI and retail with Broadcom, MongoDB, Target and Macy due to report. Jobs data could set the Fed's rate cut tone.
Turnaround play GM and energy drink maker Celsius lead this watchlist.
SWAV earnings call for the period ending December 31, 2023.
ShockWave Medical reports Q4 2023 financial results, beating EPS and revenue expectations.
SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...
Shockwave Medical (SWAV) said it has appointed Renee Gaeta as its CFO, effective February 5, 2024. Gaeta, who most recently served as the finance chief at Ek
SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...
SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and...
SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...
SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the Piper Sandler 35th Annual Healthcare Conference, which is being held from Tuesday, November 28 to Thursday, November 30, 2023 in New York, NY.
MedTech stocks rally after Novo Nordisk (NVO) disappoints with Phase 3 cardiovascular data for its weight loss therapy, Wegovy. Read more here.